Polar Capital Global Healthcare Trust

Daniel joined Polar Capital in 2007 to set up the healthcare team. He joined from Morgan Stanley, where he was head of its European healthcare research team, covering the biotechnology, medical technology and healthcare services. Before joining the investment industry, Daniel was also a research scientist and worked at Plough Corporation in California. He has a PHD from Cambridge University and graduated with a first class honours degree in biochemistry from Oxford University in 1991.

Gareth also joined Polar Capital in 2007 to set up the healthcare team. He started his career in investment management with Framlington in 1999 and became the manager of the Framlington Health fund in 2002. He also helped to launch the Framlington Biotech fund, which he managed from 2004 until his departure. Gareth studied biotechnology at Oxford and, as part of his course, worked at a leading Japanese pharmaceutical company. Gareth has also worked at various academic laboratories, including the Sir William Dunn School of Pathology, The Wolfson Institute for Medical Research and Oxford Business School.

James became a co-manager for the trust in September 2018. He joined Polar Capital in September 2015 and has 19 years of industry experience. Prior to joining Polar Capital, James worked in equity sales, specialising in global healthcare at Morgan Stanley, RBS and HSBC. James also has equity research experience garnered from his time at UBS, where he worked as an analyst in the European pharmaceutical and biotechnology team. Before moving across to the financial sector, he worked as a consultant for EvaluatePharma. James has a PHD and first class honours degree in Medicinal Chemistry from Newcastle University. He also holds an ACCA diploma in financial management.